| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Clopidogrel | FAERS: 30 | US FAERS | |
| 2 | Captopril | FAERS: 8 | US FAERS | |
| 3 | Clopidogrel | FAERS: 8 | US FAERS | |
| 4 | Methimazole | FAERS: 3 | SIDER US FAERS | |
| 5 | Sitagliptin Phosphate | FAERS: 2 | US FAERS | |
| 6 | candesartan | FAERS: 2 | US FAERS | |
| 7 | insulin aspart, insulin aspart protamine drug combination 30:70 | FAERS: 2 | US FAERS | |
| 8 | Cilostazol | FAERS: 1 | US FAERS | |
| 9 | Insulin Glargine | FAERS: 1 | US FAERS | |
| 10 | Insulin | FAERS: 1 | US FAERS | |
| 11 | Topiramate | FAERS: 1 | US FAERS | |
| 12 | Valsartan | FAERS: 1 | US FAERS | |
| 13 | candesartan cilexetil | FAERS: 1 | US FAERS | |
| 14 | glimepiride | FAERS: 1 | US FAERS | |
| 15 | Famotidine | OFFSIDES | ||
| 16 | Triazolam | OFFSIDES | ||
| 17 | alfacalcidol | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120326
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.